MV Capital Management
CRL icon

MV Capital Management’s Charles River Laboratories CRL Stock Holding History

MV Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$24.5K Sell
83
-2
-2% -$527 ﹤0.01% 423
2026
Q2 		$19.3K Buy
85
+7
+9% +$1.25K ﹤0.01% 465
2026
Q1 		$13.5K Buy
78
+1
+1% +$185 ﹤0.01% 489
2025
Q4 		$15.4K Hold
77
– – ﹤0.01% 474
2025
Q3 		$12K Buy
77
+4
+5% +$635 ﹤0.01% 493
2025
Q2 		$11.1K Buy
73
+35
+92% +$4.67K ﹤0.01% 510
2025
Q1 		$5.72K Buy
38
+17
+81% +$2.85K ﹤0.01% 599
2024
Q4 		$3.88K Sell
21
-5
-19% -$963 ﹤0.01% 632
2024
Q3 		$5.12K Sell
26
-3
-10% -$623 ﹤0.01% 625
2024
Q2 		$5.99K Buy
29
+5
+21% +$1.13K ﹤0.01% 588
2024
Q1 		$6.5K Buy
24
+1
+4% +$239 ﹤0.01% 574
2023
Q4 		$5.44K Buy
23
+8
+53% +$1.57K ﹤0.01% 592
2023
Q3 		$2.94K Hold
15
– – ﹤0.01% 625
2023
Q2 		$3.15K Buy
15
+7
+88% +$1.39K ﹤0.01% 620
2023
Q1 		$1.62K Buy
8
+1
+14% +$227 ﹤0.01% 653
2022
Q4 		$1.52K Buy
7
+1
+17% +$218 ﹤0.01% 624
2022
Q3 		$1K Hold
6
– – ﹤0.01% 648
2022
Q2 		$1K Sell
6
-5
-45% -$1.22K ﹤0.01% 644
2022
Q1 		$3K Buy
11
+8
+267% +$2.47K ﹤0.01% 629
2021
Q4 		$1K Sell
3
-4
-57% -$1.55K ﹤0.01% 674
2021
Q3 		$3K Buy
+7
New +$2.91K ﹤0.01% 636
2018
Q4 		– Sell
-45
Closed -$6K – 328
2018
Q3 		$6K Hold
45
– – ﹤0.01% 283
2018
Q2 		$5K Hold
45
– – ﹤0.01% 308
2018
Q1 		$5K Hold
45
– – ﹤0.01% 305
2017
Q4 		$5K Buy
+45
New +$4.9K ﹤0.01% 299

Other funds holding CRL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Cooke & Bieler
Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Van Berkom & Associates
Van Berkom & Associates Montreal, Quebec, Canada $2.81B AUM 6.02% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

MV Capital Management's CRL Position: Q3 2026 in Review

MV Capital Management reduced its Charles River Laboratories (CRL) stake by 2.4% in Q3 2026, selling an estimated $527 and leaving 83 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #423.

MV Capital Management first reported a position in CRL in Q4 2017 and has held it in 25 quarters since. 285 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • MV Capital Management held 83 shares of Charles River Laboratories worth $24.5K as of Q3 2026.
  • MV Capital Management sold 2 Charles River Laboratories shares in Q3 2026, an estimated $527.
  • Charles River Laboratories made up ﹤0.01% of MV Capital Management's portfolio in Q3 2026, its #423 holding.
  • MV Capital Management first reported a position in Charles River Laboratories in Q4 2017 and has held it in 25 quarters since.
  • 285 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on MV Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.